Jon P. Stonehouse - Dec 19, 2023 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
President & CEO, Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Dec 19, 2023
Transactions value $
-$85,238
Form type
4
Date filed
12/20/2023, 04:40 PM
Previous filing
Dec 18, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Tax liability -$85.2K -14.1K -1.25% $6.05 1.11M Dec 19, 2023 Direct F1
holding BCRX Common Stock 10K Dec 19, 2023 By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust
holding BCRX Common Stock 10K Dec 19, 2023 By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.